| Date Filed | Type | Description |
| 07/27/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/12/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 12/01/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/29/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/14/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/04/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/26/2022 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 10/24/2022 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 08/10/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/31/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/25/2022 |
SC 13D
| Syncona Portfolio Ltd reports a 62.3% stake in Freeline Therapeutics Holdings plc |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/11/2022 |
SC 13G
| Syncona Portfolio Ltd reports a 27.3% stake in Achilles Therapeutics plc |
| 02/11/2022 |
SC 13G/A
| Syncona Portfolio Ltd reports a 26.8% stake in Autolus Therapeutics plc |
| 02/11/2022 |
SC 13G/A
| Syncona Portfolio Ltd reports a 52.5% stake in Freeline Therapeutics Holdings plc |
| 02/12/2021 |
SC 13G
| Syncona Portfolio Ltd reports a 54.2% stake in Freeline Therapeutics Holdings plc |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| Syncona Portfolio Ltd reports a 32.4% stake in Autolus Therapeutics plc |
| 06/11/2019 |
4
| Syncona Portfolio Ltd (10% Owner) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 13,203,922 shares
@ $25.5, valued at
$336.7M
|
|
| 03/14/2019 |
SC 13G/A
| Syncona Portfolio Ltd reports a 39% stake in Nightstar Therapeutics plc |
| 02/14/2019 |
SC 13G/A
| Syncona Portfolio Ltd reports a 33.9% stake in Autolus Therapeutics plc |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G
| Syncona Portfolio Ltd reports a 33.9% stake in Autolus Therapeutics plc |
| 02/13/2019 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 01/02/2019 |
3
| Syncona Portfolio Ltd (10% Owner) has filed a Form 3 on Nightstar Therapeutics plc |
| 02/02/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |